title: Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?
authors.affiliation: University of Manitoba, Winnipeg, Canada.
authors.forename: Adarshdip
authors.initials: A
authors.lastname: Brar
authors.forename: Timothy
authors.initials: T
authors.lastname: Hiebert
authors.forename: Hani
authors.initials: H
authors.lastname: El-Gabalawy
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009369:Neoplasms / Q000209:etiology* / Q000276:immunology; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha